Sponsor:
Modulation Therapeutics, Inc.
Code:
NCT05496686
Conditions
Uveal Melanoma
Metastatic
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
4.7 microCi 225Ac-MTI-201
9.5 microCi of 225Ac-MTI-201
19 microCi of 225Ac-MTI-201
38 microCi of 225Ac-MTI-201
76 microCi of 225Ac-MTI-201
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-26. This information was provided to ClinicalTrials.gov by Modulation Therapeutics, Inc. on 2025-10-30.